Free Trial
NYSE:SOLV

Solventum (SOLV) Stock Price, News & Analysis

Solventum logo
$76.24 -2.26 (-2.88%)
Closing price 03:59 PM Eastern
Extended Trading
$76.24 +0.01 (+0.01%)
As of 06:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Solventum Stock (NYSE:SOLV)

Key Stats

Today's Range
$76.16
$78.86
50-Day Range
$65.57
$78.21
52-Week Range
$47.16
$85.92
Volume
924,033 shs
Average Volume
1.12 million shs
Market Capitalization
$13.19 billion
P/E Ratio
35.30
Dividend Yield
N/A
Price Target
$81.50
Consensus Rating
Hold

Company Overview

Solventum Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
16th Percentile Overall Score

SOLV MarketRank™: 

Solventum scored higher than 16% of companies evaluated by MarketBeat, and ranked 850th out of 913 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Solventum has received a consensus rating of Hold. The company's average rating score is 2.18, and is based on 3 buy ratings, 7 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Solventum has only been the subject of 3 research reports in the past 90 days.

  • Read more about Solventum's stock forecast and price target.
  • Earnings Growth

    Earnings for Solventum are expected to decrease by -16.57% in the coming year, from $6.58 to $5.49 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Solventum is 35.30, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.67.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Solventum is 35.30, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.19.

  • Price to Earnings Growth Ratio

    Solventum has a PEG Ratio of 2.01. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Solventum has a P/B Ratio of 4.45. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Solventum's valuation and earnings.
  • Percentage of Shares Shorted

    3.03% of the float of Solventum has been sold short.
  • Short Interest Ratio / Days to Cover

    Solventum has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Solventum has recently decreased by 6.67%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Solventum does not currently pay a dividend.

  • Dividend Growth

    Solventum does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.03% of the float of Solventum has been sold short.
  • Short Interest Ratio / Days to Cover

    Solventum has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Solventum has recently decreased by 6.67%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Solventum has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 12 news articles for Solventum this week, compared to 12 articles on an average week.
  • Search Interest

    2 people have searched for SOLV on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    Only 3 people have added Solventum to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
Receive SOLV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Solventum and its competitors with MarketBeat's FREE daily newsletter.

SOLV Stock News Headlines

Argus Upgrades Solventum (NYSE:SOLV) to Buy
Top Picks for Trump’s Pro-Crypto America
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
See More Headlines

SOLV Stock Analysis - Frequently Asked Questions

Solventum's stock was trading at $66.06 on January 1st, 2025. Since then, SOLV stock has increased by 15.4% and is now trading at $76.24.

Solventum Corporation (NYSE:SOLV) posted its quarterly earnings data on Thursday, May, 8th. The company reported $1.34 EPS for the quarter, topping the consensus estimate of $1.19 by $0.15. The company's revenue for the quarter was up 2.7% on a year-over-year basis.
Read the conference call transcript
.

Shares of SOLV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Solventum investors own include Chevron (CVX), American Water Works (AWK), The RMR Group (RMR), Bristol Myers Squibb (BMY), DiamondRock Hospitality (DRH), Waste Connections (WCN) and AU Optronics (AUOTY).

Company Calendar

Last Earnings
5/08/2025
Today
7/07/2025
Next Earnings (Estimated)
8/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Medical Equipment
Current Symbol
NYSE:SOLV
Previous Symbol
NYSE:SOLV
Fax
N/A
Employees
22,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$81.50
High Stock Price Target
$90.00
Low Stock Price Target
$71.00
Potential Upside/Downside
+6.9%
Consensus Rating
Hold
Rating Score (0-4)
2.18
Research Coverage
11 Analysts

Profitability

Trailing P/E Ratio
35.30
Forward P/E Ratio
11.59
P/E Growth
2.01
Net Income
$478 million
Pretax Margin
3.78%

Debt

Sales & Book Value

Annual Sales
$8.25 billion
Cash Flow
$9.65 per share
Price / Cash Flow
7.90
Book Value
$17.13 per share
Price / Book
4.45

Miscellaneous

Free Float
172,926,000
Market Cap
$13.19 billion
Optionable
Optionable
Beta
0.55
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NYSE:SOLV) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners